Unmet Needs in Myasthenia Gravis: What KOLs Say Must Change | REACH MarketVue® Amanda Theocles2026-07-13T20:05:43+00:00July 13th, 2026|MarketVue, Neurology, Neuromuscular, Physician Insights, Press Release| Read More
What It Will Take to Modify the Course of Huntington’s Disease | REACH MarketVue® Amanda Theocles2026-06-18T20:17:57+00:00June 19th, 2026|MarketVue, Neurology, Physician Insights, Press Release| Read More
First-Generation ASOs in Angelman Syndrome: A Promising Start, With Room to Improve | REACH MarketVue® Amanda Theocles2026-06-17T15:51:09+00:00June 18th, 2026|MarketVue, Neurology, Physician Insights, Press Release| Read More
Three Critical Gaps in Dravet Syndrome Care – and Why Genetic Therapy Changes Everything | REACH MarketVue® Amanda Theocles2026-06-16T16:44:12+00:00June 16th, 2026|MarketVue, Neurology, Physician Insights, Press Release| Read More
Fragile X Syndrome: Where Behavioral Control and Cognitive Gain Remain Out of Reach | REACH MarketVue® Amanda Theocles2026-06-15T16:50:05+00:00June 15th, 2026|MarketVue, Neurology, Physician Insights, Press Release| Read More
The Disease-Modifying Era in Angelman Syndrome Amanda Theocles2026-06-10T18:49:00+00:00February 26th, 2026|MarketVue, Neurology, Physician Insights| Read More
Why Tissue Type Matters Most in the Next Phase of DM1 Therapeutics Amanda Theocles2026-06-10T18:43:44+00:00February 24th, 2026|MarketVue, Neurology, Physician Insights| Read More
The Unyielding Unmet Need in Huntington’s Disease Amanda Theocles2026-06-10T18:37:06+00:00February 24th, 2026|MarketVue, Neurology, Physician Insights| Read More
